drugset / Trial / NCT00894686
Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
Non-randomizedOpen-labelPrevention
Summary
The main purpose of this study is to assess the seropersistence of TBE virus antibodies in children, adolescents and young adults who received the first booster vaccination with either FSME-IMMUN 0.25 mL Junior or FSME-IMMUN 0.5 mL in precursor Study 700401.
Timeline
- Start
- 2009-04-26
- Primary completion
- 2017-05-10
- Completion
- 2017-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FSME-IMMUN | Vaccine | 0.25 ml | Intramuscular |
| Subject | FSME-IMMUN | Vaccine | 0.5 ml | Intramuscular |